{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:38:42Z","timestamp":1777880322206,"version":"3.51.4"},"reference-count":32,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prim Dent J"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:p>When undertaking dental extractions in modern dental practice, two of the complications that have the potential to cause most apprehension for clinicians are the risks of osteonecrosis of the jaws and uncontrollable haemorrhage. This is especially the case when treating older patients because of the increased likelihood of co-morbidities and accompanying polypharmacy which can predispose patients to these problems. Specific medications of concern to practitioners in relation to osteonecrosis risk are antiangiogenic and antiresorptive drugs. Patients taking dual antiplatelet therapy and direct oral anticoagulants require consideration in relation to bleeding risk. With these medications coming increasingly to the forefront over recent years, guidance has been developed by organisations such as the Scottish Dental Clinical Effectiveness Programme (SDCEP). Appropriate use of these guideline should ensure that patients felt to be at particular risk of these complications can frequently be safely managed in primary care. This article aims to provide advice on recognising patients at risk, and to discuss how to utilise key messages within published guidelines when making treatment decisions. The overall intent is to help primary care clinicians who are likely to encounter these patients more and more.<\/jats:p>","DOI":"10.1177\/2050168420943977","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T06:12:25Z","timestamp":1602655945000},"page":"54-58","source":"Crossref","is-referenced-by-count":5,"title":["Managing Patients at Risk of Medication Related Complications Requiring Dental Extractions in Primary Care"],"prefix":"10.1177","volume":"9","author":[{"given":"Jamie","family":"Toole","sequence":"first","affiliation":[{"name":"Consultant\/Honorary Clinical Lecturer in Oral Surgery, Centre for Dentistry, Queen\u2019s University Belfast"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerry","family":"McKenna","sequence":"additional","affiliation":[{"name":"Senior Lecturer\/Consultant in Restorative Dentistry, Centre for Public Health, Queen\u2019s University Belfast"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Smyth","sequence":"additional","affiliation":[{"name":"Clinical Teaching Fellow in Oral Surgery, Centre for Dentistry, Queen\u2019s University Belfast"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,9,17]]},"reference":[{"key":"bibr1-2050168420943977","unstructured":"The Health and Social Care Information Centre. Executive Summary: Adult Dental Health Survey 2009. [Internet]. London: The Health and Social Care Information Centre; 2009. Available at https:\/\/files.digital.nhs.uk\/publicationimport\/pub01xxx\/pub01086\/adul-dent-heal-surv-summ-them-exec-2009-rep2.pdf."},{"key":"bibr2-2050168420943977","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2009.07.097"},{"key":"bibr3-2050168420943977","unstructured":"Faculty of General Dental Practice (UK). National study on avascular necrosis of the jaws including bisphosphonate-related necrosis. [Internet]. London: Faculty of General Dental Practice (UK); 2012. Available at https:\/\/www.fgdp.org.uk\/sites\/fgdp.org.uk\/files\/docs\/in-practice\/amps-online\/final%20report-27.11.12.pdf"},{"key":"bibr4-2050168420943977","volume-title":"[Internet]","author":"International Osteoporosis Foundation","year":"2019"},{"key":"bibr5-2050168420943977","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07088-2"},{"key":"bibr6-2050168420943977","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1479"},{"key":"bibr7-2050168420943977","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2006.10.061"},{"key":"bibr8-2050168420943977","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ebd.6401176"},{"key":"bibr9-2050168420943977","unstructured":"The Scottish Dental Clinical Effectiveness Programme (SDCEP). Oral Health Management of Patients at Risk of Medication-related Osteonecrosis of the Jaw. [Internet]. Glasgow: NHS Scotland; 2017. Available at http:\/\/www.sdcep.org.uk\/wp-content\/uploads\/2017\/04\/SDCEP-Oral-Health-Management-of-Patients-at-Risk-of-MRONJ-Guidance-full.pdf."},{"key":"bibr10-2050168420943977","unstructured":"The Scottish Dental Clinical Effectiveness Programme (SDCEP). Oral Health Management of Patients at Risk of Medication-related Osteonecrosis of the Jaw: Guidance in Brief. [Internet]. Glasgow: NHS Scotland; 2017. Available at http:\/\/www.sdcep.org.uk\/wp-content\/uploads\/2017\/04\/SDCEP-Oral-Health-Management-of-Patients-at-Risk-of-MRONJ-Guidance-in-Brief.pdf."},{"key":"bibr11-2050168420943977","doi-asserted-by":"publisher","DOI":"10.1016\/j.acthis.2019.02.007"},{"key":"bibr12-2050168420943977","doi-asserted-by":"publisher","DOI":"10.1111\/odi.12908"},{"key":"bibr13-2050168420943977","unstructured":"American Association of Oral and Maxillofacial Surgeons. Medication-Related Osteonecrosis of the Jaw - 2014 Update. [Internet]. New York, USA: American Association of Oral and Maxillofacial Surgeons; 2014. Available at https:\/\/www.aaoms.org\/docs\/govt_affairs\/advocacy_white_papers\/mronj_position_paper.pdf."},{"key":"bibr14-2050168420943977","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.b.31500"},{"key":"bibr15-2050168420943977","unstructured":"National Institute of Health and Care Excellence (NICE). Antiplatelet treatment. [Internet]. London: NICE; 2018. Available at https:\/\/cks.nice.org.uk\/antiplatelet-treatment#!scenario:1."},{"key":"bibr16-2050168420943977","doi-asserted-by":"publisher","DOI":"10.1007\/s00784-018-2591-y"},{"issue":"1","key":"bibr17-2050168420943977","first-page":"68","volume":"15","author":"Zabojszcz M","year":"2019","journal-title":"Postepy Kardiol Interwencyjnej"},{"key":"bibr18-2050168420943977","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2018.08.019"},{"issue":"1","key":"bibr19-2050168420943977","doi-asserted-by":"crossref","DOI":"10.4103\/ccd.ccd_702_17","volume":"9","author":"Babaji P","year":"2018","journal-title":"Contemp Clin Dent"},{"key":"bibr20-2050168420943977","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijom.2016.02.010"},{"key":"bibr21-2050168420943977","doi-asserted-by":"publisher","DOI":"10.1016\/j.adaj.2017.09.052"},{"key":"bibr22-2050168420943977","unstructured":"The Scottish Dental Clinical Effectiveness Programme (SDCEP). Management of Dental Patients Taking Anticoagulants or Antiplatelet Drugs. [Internet]. Glasgow: NHS Scotland; 2015. Available at http:\/\/www.sdcep.org.uk\/wp-content\/uploads\/2015\/09\/SDCEP-Anticoagulants-Guidance.pdf."},{"key":"bibr23-2050168420943977","unstructured":"The Scottish Dental Clinical Effectiveness Programme (SDCEP). Management of Dental Patients Taking Anticoagulants or Antiplatelet Drugs: Quick Reference Guide. [Internet]. Glasgow: NHS Scotland; 2015. Available at http:\/\/www.sdcep.org.uk\/wp-content\/uploads\/2015\/09\/SDCEP-Anticoagulants-Quick-Reference-Guide.pdf."},{"key":"bibr24-2050168420943977","doi-asserted-by":"publisher","DOI":"10.1007\/s00784-018-2739-9"},{"key":"bibr25-2050168420943977","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2016.06.003"},{"key":"bibr26-2050168420943977","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijom.2019.01.013"},{"key":"bibr27-2050168420943977","first-page":"6208604","volume":"2019","author":"Ehrhard S","year":"2019","journal-title":"Case Rep Emerg Med"},{"key":"bibr28-2050168420943977","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.32.3.359"},{"key":"bibr29-2050168420943977","unstructured":"HMS Government. GOV.UK. Bevacizumab and sunitinib: risk of osteonecrosis of the jaw. London: HMS Government; 2011. Available at https:\/\/www.gov.uk\/drug-safety-update\/bevacizumab-and-sunitinib-risk-of-osteonecrosis-of-the-jaw."},{"key":"bibr30-2050168420943977","unstructured":"HMS Government. GOV.UK. Aflibercept (Zaltrap): minimising the risk of osteonecrosis of the jaw. London: HMS Government; 2011. Available at https:\/\/www.gov.uk\/drug-safety-update\/aflibercept-zaltrap-minimising-the-risk-of-osteonecrosis-of-the-jaw."},{"key":"bibr31-2050168420943977","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-013-0060-1"},{"key":"bibr32-2050168420943977","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13651"}],"container-title":["Primary Dental Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2050168420943977","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2050168420943977","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2050168420943977","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:07:58Z","timestamp":1777594078000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2050168420943977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.1177\/2050168420943977"],"URL":"https:\/\/doi.org\/10.1177\/2050168420943977","relation":{},"ISSN":["2050-1684","2050-1692"],"issn-type":[{"value":"2050-1684","type":"print"},{"value":"2050-1692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]}}}